Thymidine Phosphorylase Regulates the Expression of CXCL10 in Rheumatoid Arthritis Fibroblast‐like Synoviocytes
暂无分享,去创建一个
T. Furukawa | S. Akiyama | T. Nakajima | S. Sone | Y. Nishioka | M. Hanibuchi | Atsuro Saijo | A. Mitsuhashi | H. Kawano | Sho Tabata | Y. Aono | J. Kishi | H. Goto | T. Kuramoto | H. Horikawa | Yuko Toyoda
[1] T. Furukawa,et al. Thymidine phosphorylase enhances reactive oxygen species generation and interleukin-8 expression in human cancer cells. , 2012, Oncology reports.
[2] Li-an Xu,et al. A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis. , 2012, Arthritis and rheumatism.
[3] M. Nozaki,et al. The Sp1 transcription factor is essential for the expression of gliostatin/thymidine phosphorylase in rheumatoid fibroblast-like synoviocytes , 2012, Arthritis Research & Therapy.
[4] S. Kuhara,et al. Gene expression analysis of rheumatoid arthritis synovial lining regions by cDNA microarray combined with laser microdissection: up-regulation of inflammation-associated STAT1, IRF1, CXCL9, CXCL10, and CCL5 , 2012, Scandinavian journal of rheumatology.
[5] B. Sherry,et al. CXCL10 and its receptor CXCR3 regulate synovial fibroblast invasion in rheumatoid arthritis. , 2011, Arthritis and rheumatism.
[6] M. Aoyama,et al. FK506 inhibition of gliostatin/thymidine phosphorylase production induced by tumor necrosis factor-α in rheumatoid fibroblast-like synoviocytes , 2011, Rheumatology International.
[7] E. Lee,et al. Potential role and mechanism of IFN-gamma inducible protein-10 on receptor activator of nuclear factor kappa-B ligand (RANKL) expression in rheumatoid arthritis , 2011, Arthritis research & therapy.
[8] Z. Chen,et al. Genome‐wide haplotype association analysis and gene prioritization identify CCL3 as a risk locus for rheumatoid arthritis , 2010, International journal of immunogenetics.
[9] L. Tam,et al. CXCL 9 and CXCL 10 as Sensitive Markers of Disease Activity in Patients with Rheumatoid Arthritis , 2010, The Journal of Rheumatology.
[10] Hélène Dumortier,et al. CXCR3, Inflammation, and Autoimmune Diseases , 2009, Annals of the New York Academy of Sciences.
[11] F. Gago,et al. The dual role of thymidine phosphorylase in cancer development and chemotherapy , 2009, Medicinal research reviews.
[12] Kazuhiko Inoue,et al. Hypoxia upregulates the expression of angiopoietin‐like‐4 in human articular chondrocytes: Role of angiopoietin‐like‐4 in the expression of matrix metalloproteinases and cartilage degradation , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[13] Seungbok Lee,et al. Reciprocal cross-talk between RANKL and interferon-gamma-inducible protein 10 is responsible for bone-erosive experimental arthritis. , 2008, Arthritis and rheumatism.
[14] Do-Young Yoon,et al. IL-32, a proinflammatory cytokine in rheumatoid arthritis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Aoyama,et al. The inhibitory effect of disease-modifying anti-rheumatic drugs and steroids on gliostatin/platelet-derived endothelial cell growth factor production in human fibroblast-like synoviocytes , 2005, Rheumatology International.
[16] H. Makino,et al. The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis , 2005, Rheumatology International.
[17] D. Witte,et al. Angiopoietin-like-4 is a potential angiogenic mediator in arthritis. , 2005, Clinical immunology.
[18] T. Furukawa,et al. The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression , 2004, Cancer science.
[19] T. Furukawa,et al. Inhibition of Metastasis of Tumor Cells Overexpressing Thymidine Phosphorylase by 2-Deoxy-l-Ribose , 2004, Cancer Research.
[20] M. Adachi,et al. A novel mechanism for the regulation of IFN-γ inducible protein-10 expression in rheumatoid arthritis , 2003, Arthritis research & therapy.
[21] A. Harris,et al. Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. , 2000, Cancer research.
[22] M. Fukushima,et al. Suppression of metastasis by thymidine phosphorylase inhibitor. , 2000, Cancer research.
[23] Shin-Seok Lee,et al. CD40 Engagement on Synovial Fibroblast Up-Regulates Production of Vascular Endothelial Growth Factor1 , 2000, The Journal of Immunology.
[24] J. Farrés,et al. Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon γ is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies , 2000, Annals of the rheumatic diseases.
[25] E. Thonar,et al. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. , 2000, Arthritis and rheumatism.
[26] M. Fukushima,et al. The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors. , 1999, Cancer research.
[27] G. Steiner,et al. Cytokine production by synovial T cells in rheumatoid arthritis. , 1999, Rheumatology.
[28] A. Dunky,et al. T cell derived cytokines in psoriatic arthritis synovial fluids , 1998, Annals of the rheumatic diseases.
[29] S. Fox,et al. Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. , 1998, British Journal of Cancer.
[30] C. Mackay,et al. Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.
[31] T. Kato,et al. Gliostatin/platelet-derived endothelial cell growth factor as a clinical marker of rheumatoid arthritis and its regulation in fibroblast-like synoviocytes. , 1997, British journal of rheumatology.
[32] H. Okumura,et al. The activity and expression of thymidine phosphorylase in human solid tumours. , 1996, European journal of cancer.
[33] J J Anderson,et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. , 1995, Arthritis and rheumatism.
[34] T. Nakajima,et al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. , 1995, Arthritis and rheumatism.
[35] T. Kato,et al. Aberrant production of gliostatin/platelet-derived endothelial cell growth factor in rheumatoid synovium. , 1994, Arthritis and rheumatism.
[36] H. Yamanaka,et al. Spontaneous production of an interleukin 1-like factor by cloned rheumatoid synovial cells in long-term culture. , 1987, The Journal of clinical investigation.
[37] J. Kyhse-Andersen. Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. , 1984, Journal of biochemical and biophysical methods.
[38] H. Ishitsuka,et al. Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine , 2004, Cancer Chemotherapy and Pharmacology.
[39] A. Gibofsky. American College of Rheumatology. , 2002, Journal of the Medical Association of Georgia.
[40] H. Paulus,et al. American College of Rheumatology 2008 Recommendations for the Use of Nonbiologic and Biologic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis , 2022 .